Back to Market Feed

GLYXAMBI 25 MG-5 MG TABLET

empagliflozin and linagliptin
$11.1925per EA

Strength

25; 5 mg/1; mg/1

NDC

00597016430

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

EMPAGLIFLOZIN; LINAGLIPTIN

Approval Type

New Drug (NDA)

FDA Application

NDA206073

On Market Since

1/30/2015

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-44.4%

1Y

-44.4%

3Y

-41.0%

5Y

-36.1%

All

-23.4%

Generic Alternatives

1 alternative • Same active ingredient

GLYXAMBI 25 MG-5 MG TABLET
Brand
00597016490•Boehringer Ingelheim Pharmaceuticals Inc.
$11.1925

Related Drugs

Same classification

ZITUVIMET XR 50-1,000 MG TABLET
Brand
70710180506•Zydus Pharmaceuticals (USA) Inc.
$5.0263
per EA
ZITUVIMET 50-1,000 MG TABLET
Brand
70710178706•Zydus Pharmaceuticals (USA) Inc.
$5.0308
per EA
ZITUVIMET 50-500 MG TABLET
Brand
70710178606•Zydus Pharmaceuticals (USA) Inc.
$5.0779
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008061•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008062•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008082•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057761•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057762•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057782•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET XR 50-500 MG TABLET
Brand
00006007861•Merck Sharp & Dohme LLC
$5.2815
per EA